≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

Endpoint Browser

C3_MACROGLOBULINEMIA

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C88.0
  • Cause of death: ICD-9 — 2733A
  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 9761|9671
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

153

4. Check minimum number of events

None

153

5. Include endpoints

None

153

6. Filter based on genotype QC (FinnGen only)

145

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF8

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 145 59 86
Unadjusted period prevalence (%) 0.03 0.02 0.04
Median age at first event (years) 70.01 66.95 72.11

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
153
Matched controls
1530
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
187.5
139
*
XW000
NOMESCO Finland
Bone marrow biopsy
99.4
153.2
85
19
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
422.1
119.0
106
8
9761/3-C42.0
ICD-O-3
Waldenstrom macroglobulinemia of blood
+∞
111.5
93
*
A04AA01
ATC
ondansetron; systemic, rectal
80.6
96.2
53
10
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
30.5
61.9
44
20
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
92.9
42.9
46
7
9671/3-C42.1
ICD-O-3
Lymphoplasmacytic lymphoma of bone marrow
+∞
41.6
38
*
L03AA02
ATC
filgrastim; parenteral
+∞
40.4
37
*
H02AB02
ATC
dexamethasone; systemic
172.9
38.8
39
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
92.3
38.2
41
6
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
14.9
36.5
36
31
JN4BD
NOMESCO Finland
Extensive body CT
12.5
35.8
40
42
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
26.9
25
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
26.9
25
*
JN4AD
NOMESCO Finland
Body CT examination
10.1
26.7
34
42
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
310.7
26.6
26
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.0
24.8
46
88
390
Kela drug reimbursment
Ibrutinib
+∞
23.5
22
*
1512
Kela drug reimbursment
Ibrutinib
+∞
23.5
22
*
M04AA01
ATC
allopurinol; systemic
5.3
21.5
61
171
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
21.3
20
*
L03AA13
ATC
pegfilgrastim; parenteral
228.3
20.1
20
*
ZX120
NOMESCO Finland
Intravenous
7.7
19.7
31
49
A03FA01
ATC
metoclopramide; systemic, rectal
6.3
19.5
39
79
L01AA02
ATC
chlorambucil; oral
+∞
19.2
18
*
WW500
NOMESCO Finland
Blood transfusion
23.1
19.0
27
14
L01EL01
ATC
ibrutinib; oral
+∞
18.1
17
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
18.1
17
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
18.1
17
*
J05AB01
ATC
aciclovir; systemic
4.6
18.0
60
188
R50.9
ICD-10 Finland
Fever, unspecified
4.4
14.0
43
124
C90.0
ICD-10 Finland
Multiple myeloma
+∞
13.7
13
*
D64.9
ICD-10 Finland
Anaemia, unspecified
4.5
13.4
39
108
J05AB11
ATC
valaciclovir; oral
4.1
12.7
43
133
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
12.7
12
*
B02.9
ICD-10 Finland
Zoster without complication
5.2
12.2
28
63
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.6
12.2
21
36
1XC02, ,
NOMESCO Finland
70.5
11.8
13
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
11.6
11
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
11.6
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
11.6
11
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
11.6
97
526
WZC00
NOMESCO Finland
Treatment plan or consultation
3.3
11.0
57
232
L01AA01
ATC
cyclophosphamide; systemic
117.8
10.6
11
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.5
10
*
L01XE27
ATC
[U] ibrutinib
+∞
10.5
10
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
10.5
10
*
JN6AD
NOMESCO Finland
CT of torso and neck
35.2
10.5
13
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
8.5
9.8
21
28
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.5
9
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
9.5
9
*
N08.1*C88.0
ICD-10 Finland
Glomerular disorders in Waldenström's macroglobulinaemia
+∞
9.5
9
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
+∞
9.5
9
*
B03XA02
ATC
darbepoetin alfa; parenteral
17.0
9.2
14
9
B03XA01
ATC
erythropoietin; parenteral
39.2
9.1
11
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
8.5
48
201
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
95.1
8.5
9
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.4
8
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
8.4
8
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.5
8.4
22
55
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
7.8
62
311
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.3
7.7
21
54
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
7.7
30
100
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
7.7
45
192
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
14.3
7.5
12
9
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.7
7.5
26
80
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
84.0
7.5
8
*
130
Kela drug reimbursment
Malignant tumour
+∞
7.3
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
7.3
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.3
7
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
7.3
7
*
115
Kela drug reimbursment
Breast cancer
+∞
7.3
7
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
6.7
41
178
L57.0
ICD-10 Finland
Actinic keratosis
3.7
6.6
22
66
J01MA12
ATC
levofloxacin; systemic
2.7
6.5
41
180
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
72.8
6.5
7
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
27.9
6.3
8
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
6.3
6
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
6.3
6
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.3
6
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
6.3
6
*
H02AB06
ATC
prednisolone; systemic
2.3
6.1
85
535
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
6.0
59
319
Z51.5
ICD-10 Finland
Palliative care
6.9
6.0
14
22

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
125
58
113.30
188.99
14.4
1.4
14.59
1.08
g/l
19.37
120
51
93
17
137.95
175.49
2.2
1.4
—
—
—
0
0
103
33
93.45
172.31
8.0
1.2
39.22
36.24
mg/l
0.09
85
27
103
33
93.45
172.31
8.1
1.2
109.55
52.71
mg/l
2.02
86
27
122
81
70.40
157.81
12.8
1.2
—
—
—
0
0
83
20
89.52
146.86
7.6
1.1
—
—
—
0
0
71
16
81.93
126.24
1.5
1.6
—
—
—
0
0
77
47
31.97
98.75
12.5
1.1
16.72
10.09
g/l
4.15
70
39
64
43
24.87
77.20
12.7
1.1
38.05
37.83
g/l
0.07
57
35
45
12
52.71
75.12
2.0
1.0
—
—
—
0
0
56
31
27.92
73.49
1.6
1.2
—
—
—
0
0
86
106
17.24
72.88
5.2
2.2
58.93
64.34
e9/l
0.67
63
81
96
147
15.85
69.45
5.5
2.1
1.52
1.60
%
0.41
89
131
70
9
141.26
69.38
1.3
1.0
—
—
—
0
0
61
56
17.45
61.33
2.1
1.7
1.46
1.48
g/l
0.05
53
49
64
77
13.57
53.53
1.5
1.3
—
—
—
0
0
69
98
12.00
50.93
1.6
1.4
—
—
—
0
0
92
187
10.83
50.66
4.6
1.3
1.71
2.83
g/l
1.26
80
96
50
45
16.02
50.22
1.3
1.3
—
—
—
0
0
60
76
12.34
47.97
1.5
1.4
—
—
—
0
0
43
0
+∞
47.39
2.6
0.0
1.94
—
mpas
—
28
0
128
498
10.61
34.50
18.4
5.3
—
—
—
0
0
69
151
7.50
33.50
6.2
4.9
1.02
1.03
mmol/l
0.10
64
133
68
148
7.47
33.16
3.0
2.5
23.34
24.50
%
0.24
61
133
38
11
45.34
31.45
1.1
1.1
—
—
—
0
0
29
0
+∞
31.33
1.9
0.0
16.80
—
titre
—
5
0
130
552
10.01
30.68
15.2
5.0
1.92
1.80
e9/l
0.61
124
483
129
545
9.71
30.55
15.1
4.8
0.68
0.60
e9/l
2.01
121
469
129
547
9.66
30.37
15.1
4.8
0.04
0.04
e9/l
1.19
121
473
131
567
10.11
30.07
16.0
4.9
0.16
0.20
e9/l
2.13
124
489
97
326
6.40
29.11
7.4
2.5
333.89
5913.19
umol/l
1.31
92
283
100
353
6.29
28.14
13.0
3.2
7.41
7.40
ph
0.81
25
49
131
605
9.10
26.79
28.2
5.5
3.53
4.37
e9/l
4.73
122
525
129
605
8.22
25.35
16.5
5.4
1.22
1.21
mmol/l
0.86
106
529
42
74
7.44
24.43
7.7
3.9
0.72
0.85
%
0.19
29
24
37
66
7.08
21.09
8.4
4.1
0.21
0.37
%
0.27
24
19
37
68
6.86
20.47
8.2
4.1
0.04
0.11
%
0.37
24
18
80
299
4.51
19.22
2.8
2.0
2.76
2.88
mg/l
0.17
67
252
89
370
4.36
18.27
5.2
2.0
2.36
2.35
mmol/l
0.23
77
306
33
66
6.10
16.60
8.7
4.0
0.00
0.06
%
0.48
20
16
80
337
3.88
15.51
8.8
3.8
—
—
—
0
0
77
330
3.68
14.28
2.1
1.5
20.35
20.65
nmol/l
0.06
66
285
29
59
5.83
14.24
3.7
1.4
2.90
2.76
ug/l
0.08
22
42
18
9
22.42
12.80
4.4
1.6
—
—
—
0
0
19
12
17.86
12.51
2.9
1.6
33.21
33.00
pg
0.07
19
12
15
6
27.48
11.38
1.4
1.3
—
—
—
0
0
18
15
13.42
10.66
1.1
1.3
—
—
—
0
0
80
412
2.97
10.04
5.8
3.6
53.21
125.38
e6/l
0.75
62
292
67
314
3.02
9.97
4.7
2.7
—
—
—
0
0
69
329
3.00
9.95
2.7
1.5
—
—
—
0
0
73
362
2.94
9.76
5.1
3.0
11.10
263.89
e6/l
0.77
61
271
22
49
5.08
9.66
1.1
1.1
—
—
—
0
0
88
485
2.92
9.63
27.5
7.9
0.00
0.00
e9/l
0.49
74
394
94
551
2.83
8.92
2.8
2.0
94.65
92.07
pmol/l
0.17
56
274
67
330
2.83
8.90
4.9
2.8
0.85
0.43
e6/l
0.39
56
242
67
336
2.77
8.53
4.9
2.1
—
—
—
0
0
119
804
3.16
8.42
5.4
4.0
—
—
—
0
0
53
247
2.75
7.64
17.4
4.3
—
—
—
0
0
57
277
2.69
7.56
1.9
1.7
1174.59
1184.87
nmol/l
0.03
43
207
45
194
2.87
7.50
4.0
2.9
1.41
2.23
e6/l
0.39
27
100
53
250
2.71
7.44
3.9
2.2
2.30
3.77
e6/l
1.78
46
220
52
246
2.69
7.23
4.1
2.8
501.90
555.85
mosm/kgh2o
1.36
42
197
50
232
2.72
7.22
4.2
2.1
2.56
2.43
mmol/l
4.78
45
194
124
891
3.07
7.21
8.4
4.2
56.05
12.43
mm/h
19.47
119
798
13
14
10.03
6.94
6.3
2.6
52.31
65.43
%
1.27
13
14
13
14
10.03
6.94
4.9
1.6
2.67
5.77
e9/l
2.54
13
14
26
86
3.44
6.73
14.7
2.8
1.25
1.22
mmol/l
1.61
26
70
21
61
3.83
6.56
11.2
8.3
—
—
—
0
0
40
178
2.69
6.17
2.1
1.8
—
—
—
0
0
50
249
2.50
6.13
2.4
1.7
3.01
1.19
mg/l
0.45
40
194
12
15
8.57
5.96
1.1
1.1
—
—
—
0
0
11
12
9.77
5.89
1.6
1.2
—
—
—
0
0
17
37
5.04
5.69
2.6
1.9
0.31
0.19
g/l
—
9
8
8
5
16.76
5.47
1.4
3.0
487.00
918.60
e6/l
—
8
5
23
85
3.01
4.94
1.5
1.1
—
—
—
0
0
7
5
14.57
4.62
1.4
1.4
11.03
32.84
u/l
—
7
5
10
15
7.05
4.54
2.1
1.1
—
—
—
0
0
19
66
3.15
4.52
10.5
7.9
24.42
24.85
mmol/l
0.26
19
61
12
25
5.11
4.28
4.2
2.6
—
—
—
0
0
23
93
2.73
4.20
2.1
1.7
0.16
0.21
g/l
1.54
17
83
33
160
2.35
4.16
1.2
1.2
—
—
—
0
0
81
557
1.97
4.08
3.9
3.8
0.00
0.00
estimate
-0.00
21
84
80
549
1.96
4.04
5.2
5.1
0.00
0.00
estimate
-0.00
21
88
34
171
2.27
3.93
1.2
1.3
0.80
17.17
u/ml
—
9
57
21
84
2.74
3.91
7.0
3.1
—
—
—
0
0
10
19
5.55
3.90
5.2
2.7
—
—
—
0
0
59
369
1.97
3.87
3.3
3.1
—
—
—
0
0
79
546
1.92
3.85
4.0
3.7
0.00
0.00
estimate
-0.00
22
97
6
5
12.41
3.79
5.2
2.4
1850.00
2830.00
ml
—
6
5
12
30
4.25
3.68
1.6
1.4
—
—
—
0
0
24
106
2.50
3.68
9.3
5.7
1.16
1.50
mmol/l
1.41
24
101
89
647
1.90
3.65
19.0
16.5
1.20
1.42
inr
1.90
28
178
67
447
1.89
3.56
3.1
3.6
—
5.80
—
0
27
8
13
6.42
3.55
2.4
1.2
—
—
—
0
0
18
70
2.78
3.53
1.2
1.4
—
43.60
—
0
8
6
6
10.34
3.52
1.0
1.2
—
—
—
0
0
46
272
1.99
3.49
3.7
4.0
169.63
270.28
ng/l
0.23
38
230
11
27
4.31
3.47
2.7
3.1
—
—
—
0
0
19
77
2.68
3.45
3.8
2.8
3.31
4.38
e9/l
—
9
54
18
72
2.70
3.35
1.9
2.4
—
—
—
0
0
9
19
4.96
3.29
1.1
1.2
—
—
—
0
0
35
192
2.07
3.24
1.3
1.3
23.82
31.06
iu/ml
—
10
58
7
11
6.61
3.22
2.6
1.2
—
—
—
0
0
9
20
4.71
3.16
1.8
1.1
—
—
—
0
0
42
250
1.94
3.09
1.5
1.2
—
—
—
0
0
7
12
6.05
3.05
1.1
1.3
—
—
—
0
0
7
13
5.58
2.90
3.1
1.1
—
—
—
0
0
28
148
2.09
2.84
1.6
1.5
—
—
—
0
0
41
253
1.85
2.68
3.1
3.6
—
—
—
0
0
8
20
4.16
2.60
3.0
1.9
56.00
15.17
u/ml
—
8
12
24
124
2.11
2.58
7.2
3.1
—
—
—
0
0
9
27
3.48
2.43
4.3
2.4
—
—
—
0
0
20
99
2.17
2.39
11.6
7.1
—
—
—
0
0
5
8
6.41
2.39
1.2
1.0
—
—
—
0
0
8
24
3.46
2.21
2.1
1.0
—
—
—
0
0
17
83
2.18
2.10
4.1
4.9
7.41
7.38
ph
—
7
6
6
15
4.12
2.06
2.5
3.5
—
—
—
0
0
6
15
4.12
2.06
2.3
1.1
—
—
—
0
0
8
26
3.19
2.04
1.4
1.5
10.25
55.17
u/ml
—
8
26
21
113
1.99
2.04
2.4
1.7
340.00
359.80
nmol/l
0.20
21
101
17
85
2.13
1.99
4.1
4.8
5.09
5.16
kpa
0.14
17
80
11
45
2.56
1.98
2.1
1.9
—
—
—
0
0
5
11
4.66
1.95
2.6
1.5
89.48
88.40
%
—
5
11
6
16
3.86
1.95
1.0
1.6
—
—
—
0
0
104
873
1.60
1.93
3.2
3.5
15.06
14.97
pmol/l
0.13
89
771
17
88
2.05
1.83
1.5
1.4
—
—
—
0
0
19
105
1.92
1.72
1.4
1.2
—
—
—
0
0
112
972
1.57
1.66
52.4
15.7
14.92
15.19
%
0.31
112
954
26
162
1.73
1.63
10.3
5.1
104.92
104.34
mmol/l
0.30
26
162
22
134
1.75
1.49
1.7
1.8
—
—
—
0
0
102
878
1.49
1.48
5.0
4.2
—
—
—
0
0
41
303
1.48
1.28
4.3
3.5
—
—
—
0
0
26
371
0.64
1.26
2.8
3.5
—
—
—
0
0
17
102
1.75
1.22
1.8
1.9
257.42
120.92
ug/g
0.52
12
74
8
38
2.16
1.20
4.1
3.6
—
—
—
0
0
16
97
1.73
1.12
5.8
3.7
—
—
—
0
0
70
583
1.37
1.11
4.0
4.0
2.18
2.20
ug/l
0.01
58
517
120
1095
1.44
1.06
4.3
4.4
1.88
1.98
mu/l
0.37
110
969
133
1242
1.54
1.00
45.5
16.4
84.40
84.05
umol/l
0.04
133
1242
5
23
2.21
0.99
3.4
3.3
—
—
—
0
0
7
37
1.93
0.95
2.7
1.7
—
—
—
0
0
67
565
1.33
0.95
4.7
4.1
46.27
48.51
ng/l
0.05
52
429
49
397
1.34
0.90
3.9
4.4
—
—
—
0
0
13
84
1.60
0.74
3.2
3.0
—
—
—
0
0
5
25
2.03
0.73
1.0
1.4
—
—
—
0
0
38
306
1.32
0.72
5.2
3.9
0.00
0.00
estimate
-0.00
18
83
51
430
1.28
0.69
7.0
3.3
10562.22
216.72
mg/l
3.49
45
275
133
1265
1.39
0.65
41.3
16.9
138.95
139.74
mmol/l
2.97
133
1221
40
333
1.27
0.60
2.8
2.7
0.57
0.80
ug/l
2.29
29
230
109
1159
0.79
0.59
5.2
6.7
38.43
41.13
mmol/mol
3.92
101
1055
128
1217
1.32
0.57
31.4
13.0
—
—
—
0
0
7
46
1.55
0.49
1.4
1.3
—
—
—
0
0
106
1119
0.83
0.45
3.4
4.5
1.01
1.27
mmol/l
6.61
91
998
7
51
1.39
0.44
1.1
1.2
—
—
—
0
0
5
33
1.53
0.41
1.8
1.6
—
—
—
0
0
7
104
0.66
0.41
1.7
1.5
—
—
—
0
0
111
1163
0.83
0.41
3.8
5.0
1.40
1.45
mmol/l
0.56
97
1045
133
1286
1.26
0.38
58.8
19.7
93.90
91.63
fl
5.64
133
1253
133
1287
1.26
0.37
58.7
19.6
30.91
30.48
pg
1.95
133
1254
133
1287
1.26
0.37
60.0
19.7
36.34
40.31
%
11.41
124
1172
133
1288
1.25
0.36
59.4
19.8
120.25
136.29
g/l
21.52
133
1256
13
100
1.33
0.35
2.2
3.0
—
—
—
0
0
10
74
1.38
0.33
1.4
1.3
—
—
—
0
0
12
92
1.33
0.33
1.6
1.5
—
—
—
0
0
113
1173
0.86
0.30
3.7
5.0
4.10
4.45
mmol/l
2.61
100
1063
117
1209
0.86
0.28
4.2
5.7
2.31
2.58
mmol/l
3.22
105
1090
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
49
456
1.11
0.20
4.2
3.9
22.83
9.48
mg/mmol
0.71
35
274
7
63
1.12
0.08
4.3
5.1
—
—
—
0
0
6
71
0.84
0.08
1.3
2.1
12.50
15.94
nmol/l
—
6
65
94
954
0.96
0.05
53.2
18.0
328.19
332.20
g/l
3.50
94
944
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
0.00
0.0
9.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
280.00
—
0
9
0
9
0.00
0.00
0.0
1.3
—
182.23
—
0
9
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
83.86
—
0
7
29
290
1.00
-0.00
1.5
1.8
506.75
417.24
pmol/l
0.76
24
237
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
119
1190
1.00
-0.00
4.4
5.0
5.94
6.15
mmol/l
1.25
103
1061
0
7
0.00
-0.00
0.0
1.3
—
0.96
—
0
7
0
6
0.00
-0.00
0.0
5.3
—
26.52
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
5.3
3.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
64
0.93
-0.00
3.5
4.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
1.49
—
0
7
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_MACROGLOBULINEMIA – Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).